官方服务：
资源简介：
Efficacy and ADRs related to CYC.
应用场景：
创建时间：
2016-03-30
相关数据集
DOM FIGURE S1 Supplementary data for studies in Figure 3.
A,B. Body weights of the 1-wk study (Fig. 3A-D). C. Body weights for the 4-week and 8-week study (Fig. 3E-L). D. Liver gene expression of 1-wk treatment with PF-04991532. E-G. Plasma insulin of drug t
DataCite Commons2020-06-25 更新70
Characterizing Dupilumab Facial Redness: A Single Multi-Institution Retrospective Chart Review
Figure 1a, 1b, and 1c: Patient with Dupilumab Facial Redness
NIAID Data Ecosystem50
Supplementary file 1_Drug-induced gingival overgrowth: FAERS based real-world pharmacovigilance study and network pharmacology analysis.docx
BackgroundDrug-induced gingival overgrowth (DIGO) as an interdisciplinary clinical challenge, faces dual therapeutic barriers due to its unclear pathogenesis and high recurrence rate, forcing clinicia
NIAID Data Ecosystem00
邯郸市馆陶县-卫生-医院用药方法数据
馆陶县人民医院在开展医疗服务过程中产生的医院用药方法数据，包含药品名称、剂型剂量、给药途径、频次疗程、用药反应等。可用于合理用药指导、药效研究、不良反应监测。
河北省公共数据资源登记平台70
A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer
The main purpose of this observational study with Irinotecan onkovis is to determine the number of treatment cycles and the quantity of Irinotecan onkovis needed for this purpose under the special cir
NIAID Data Ecosystem20
